A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics

Biochimica et Biophysica Acta - Biomembranes

Volumn , Issue Part A, 2015, Pages 8-15

  He, Jing ^a   Starr, Charles G ^a   Wimley, William C ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antagonism; Antimicrobial peptide; Checkerboard; Synergy

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; CIPROFLOXACIN; MELITTIN; STREPTOMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BILAYER MEMBRANE; CONTROLLED STUDY; CYTOLYSIS; DRUG CYTOTOXICITY; DRUG MIXTURE; DRUG PENETRATION; DRUG POTENTIATION; DRUG SCREENING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HIGH THROUGHPUT SCREENING; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ALGORITHM; CELL MEMBRANE PERMEABILITY; DEVICES; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ALGORITHMS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE PERMEABILITY; DRUG SYNERGISM; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS;

EID: 84908213429     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2014.09.010     Document Type: Article

References (47)

1. E.M. D'Agata, Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: a 9-year surveillance study Infect. Control Hosp. Epidemiol. 25 2004 842 846 (PM:15518026)
2. A. Srinivasan Hunting the Nightmare Bacteria 2014 PBS Broadcasting
3. S.H. White, W.C. Wimley, and M.E. Selsted Structure, function, and membrane integration of defensins Curr. Opin. Struct. Biol. 5 1995 521 527
4. R.E. Hancock, and H.G. Sahl Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat. Biotechnol. 24 2006 1551 1557 (PM:17160061)
5. N.Y. Yount, and M.R. Yeaman Multidimensional signatures in antimicrobial peptides Proc. Natl. Acad. Sci. 101 2004 7363 7368
6. M.R. Yeaman, and N.Y. Yount Mechanisms of antimicrobial peptide action and resistance Pharmacol. Rev. 55 2003 27 55
7. D.M. Easton, A. Nijnik, M.L. Mayer, and R.E. Hancock Potential of immunomodulatory host defense peptides as novel anti-infectives Trends Biotechnol. 27 2009 582 590 (PM:19683819)
8. J.L. Gardy, D.J. Lynn, F.S. Brinkman, and R.E. Hancock Enabling a systems biology approach to immunology: focus on innate immunity Trends Immunol. 30 2009 249 262 (PM:19428301)
9. P. Hamill, K. Brown, H. Jenssen, and R.E. Hancock Novel anti-infectives: is host defence the answer? Curr. Opin. Biotechnol. 19 2008 628 636 (PM:19000763)
10. H. Jenssen, P. Hamill, and R.E. Hancock Peptide antimicrobial agents Clin. Microbiol. Rev. 19 2006 491 511 (PM:16847082)
11. A.K. Marr, W.J. Gooderham, and R.E. Hancock Antibacterial peptides for therapeutic use: obstacles and realistic outlook Curr. Opin. Pharmacol. 6 2006 468 472 (PM:16890021)
12. M.E. Selsted, and A.J. Ouellette Mammalian defensins in the antimicrobial immune response PM:15908936. Nat. Immunol. 6 2005 551 557 (PM:15908936)
13. Y.Q. Tang, M.R. Yeaman, and M.E. Selsted Antimicrobial peptides from human platelets Infect. Immun. 70 2002 6524 6533 (PM:12438321)
14. A.J. Ouellette, and M.E. Selsted Enteric defensins Curr. Opin. Gastroenterol. 13 1997 494 499
15. R. Rathinakumar, and W.C. Wimley High-throughput discovery of broad-spectrum peptide antibiotics FASEB J. 24 2010 3232 3238 (PM:20410445)
16. R. Rathinakumar, W.F. Walkenhorst, and W.C. Wimley Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: The importance of interfacial activity J. Am. Chem. Soc. 131 2009 7609 7617
17. J.M. Rausch, J.R. Marks, R. Rathinakumar, and W.C. Wimley Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes Biochemistry 46 2007 12124 12139 (PM:17918962)
18. Y. Huang, N. Wiradharma, K. Xu, Z. Ji, S. Bi, L. Li, Y.Y. Yang, W. Fan, J.E. Pollard, J. Snarr, V. Chaudhary, J.D. Jennings, H. Shaw, B. Christiansen, J. Wright, W. Jia, R.E. Bishop, and P.B. Savage Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection Biomaterials 33 2012 8841 8847 (PM:22925814;PM:22899801)
19. C.A. Arias, and B.E. Murray Antibiotic-resistant bugs in the 21st century - a clinical super-challenge N. Engl. J. Med. 360 2009 439 443 (PM:19179312)
20. U. Schwab, P. Gilligan, J. Jaynes, and D. Henke In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens Antimicrob. Agents Chemother. 43 1999 1435 1440 (PM:10348766)
21. J.E. Pollard, J. Snarr, V. Chaudhary, J.D. Jennings, H. Shaw, B. Christiansen, J. Wright, W. Jia, R.E. Bishop, P.B. Savage, Y.Y. Yang, and W. Fan In vitro evaluation of the potential for resistance development to ceragenin CSA-13 J. Antimicrob. Chemother. 67 2012 2665 2672 (PM:22899801;PM:22899801)
22. R. Daniels Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective) J. Antimicrob. Chemother. 66 Suppl. 2 2011 ii11 ii23 (PM:21398303)
23. P. Ball Conclusions: the future of antimicrobial therapy - augmentin and beyond Int. J. Antimicrob. Agents 30 Suppl. 2 2007 S139 S141 (PM:18029150)
24. T. Tangden Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria Ups. J. Med. Sci. 119 2014 149 153 (PM:24666223)
25. A.I. Zumla, S.H. Gillespie, M. Hoelscher, P.P. Philips, S.T. Cole, I. Abubakar, T.D. McHugh, M. Schito, M. Maeurer, and A.J. Nunn New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects Lancet Infect. Dis. 14 2014 327 340 (PM:24670627)
26. A. Giacometti, O. Cirioni, M.S. Del Prete, F. Barchiesi, M. Fortuna, D. Drenaggi, and G. Scalise In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia Antimicrob. Agents Chemother. 44 2000 1716 1719 (PM:10817738)
27. G. Lebel, F. Piche, M. Frenette, M. Gottschalk, and D. Grenier Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics Peptides 50C 2013 19 23 (PM:24096107)
28. A. Giacometti, O. Cirioni, F. Barchiesi, and G. Scalise In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics Diagn. Microbiol. Infect. Dis. 38 2000 115 118 (PM:11035243)
29. W.R. Greco, G. Bravo, and J.C. Parsons The search for synergy: a critical review from a response surface perspective Pharmacol. Rev. 47 1995 331 385 (PM:7568331)
30. C.R. Bonapace, J.A. Bosso, L.V. Friedrich, and R.L. White Comparison of methods of interpretation of checkerboard synergy testing Diagn. Microbiol. Infect. Dis. 44 2002 363 366 (PM:12543542)
31. M.H. Hsieh, C.M. Yu, V.L. Yu, and J.W. Chow Synergy assessed by checkerboard. A critical analysis Diagn. Microbiol. Infect. Dis. 16 1993 343 349 (PM:8495592)
32. C.R. Bonapace, R.L. White, L.V. Friedrich, and J.A. Bosso Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods Diagn. Microbiol. Infect. Dis. 38 2000 43 50 (PM:11025183)
33. R.L. White, D.S. Burgess, M. Manduru, and J.A. Bosso Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test Antimicrob. Agents Chemother. 40 1996 1914 1918 (PM:8843303)
34. R. Rathinakumar, and W.C. Wimley Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes J. Am. Chem. Soc. 130 2008 9849 9858 (PM:18611015)
35. W.C. Wimley Describing the mechanism of antimicrobial peptide action with the interfacial activity model ACS Chem. Biol. 5 2010 905 917 (PM:20698568)
36. C.E. Dempsey The actions of melittin on membranes Biochim. Biophys. Acta 1031 1990 143 161
37. M. Niu, X. Li, Q. Gong, C. Wang, C. Qin, W. Wang, and P. Chen Expression of 4kD scorpion defensin and its in vitro synergistic activity with conventional antibiotics World J. Microbiol. Biotechnol. 29 2013 281 288 (PM:23054701)
38. S. Yenugu, and G. Narmadha The human male reproductive tract antimicrobial peptides of the HE2 family exhibit potent synergy with standard antibiotics J. Pept. Sci. 16 2010 337 341 (PM:20552564)
39. S. Sanchez-Gomez, B. Japelj, R. Jerala, I. Moriyon, A.M. Fernandez, J. Leiva, S.E. Blondelle, J. Andra, K. Brandenburg, K. Lohner, and d.T. Martinez Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo Antimicrob. Agents Chemother. 55 2011 218 228 (PM:20956602)
40. D.S. van der Linden, D. Short, A. Dittmann, and P.L. Yu Synergistic effects of ovine-derived cathelicidins and other antimicrobials against Escherichia coli O157:H7 and Staphylococcus aureus 1056 MRSA Biotechnol. Lett. 31 2009 1265 1267 (PM:19396584)
41. H. Ulvatne, S. Karoliussen, T. Stiberg, O. Rekdal, and J.S. Svendsen Short antibacterial peptides and erythromycin act synergically against Escherichia coli J. Antimicrob. Chemother. 48 2001 203 208 (PM:11481289)
42. A. Giacometti, O. Cirioni, M.S. Del Prete, A.M. Paggi, M.M. D'Errico, and G. Scalise Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria Peptides 21 2000 1155 1160 (PM:11035200)
43. L. Zhang, R. Benz, and R.E. Hancock Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides Biochemistry 38 1999 8102 8111 (PM:10387056)
44. M.G. Scott, H. Yan, and R.E. Hancock Biological properties of structurally related alpha-helical cationic antimicrobial peptides Infect. Immun. 67 1999 2005 2009 (PM:10085049)
45. K. Matsuzaki, K.-I. Sugishita, M. Harada, N. Fujii, and K. Miyajima Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria Biochim. Biophys. Acta 1327 1997 119 130
46. A.J. Krauson, J. He, and W.C. Wimley Determining the mechanism of membrane permeabilizing peptides: identification of potent, equilibrium pore-formers Biochim. Biophys. Acta 1818 2012 1625 1632 (PM:22365969)
47. G. Wiedman, K. Herman, P. Searson, W.C. Wimley, and K. Hristova The electrical response of bilayers to the bee venom toxin melittin: evidence for transient bilayer permeabilization Biochim. Biophys. Acta 1828 2013 1357 1364 (PM:23384418)